StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)

Close on Nov 18, 2026Market cap $108.99MP/E –Yield –

Trinity Biotech net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$37.38M. The highest annual figure on record is $21.80M in fiscal 2015.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$37.38M–
FY2024Dec 31, 2024-$31.79M–
FY2023Dec 31, 2023-$24.02M–
FY2022Dec 31, 2022-$41.01M-4786.7%
FY2021Dec 31, 2021$875.00K–
FY2020Dec 31, 2020-$6.39M–
FY2019Dec 31, 2019-$28.91M–
FY2018Dec 31, 2018-$22.09M–
FY2017Dec 31, 2017-$40.27M–
FY2016Dec 31, 2016-$100.63M-561.7%
FY2015Dec 31, 2015$21.80M–

More Trinity Biotech figures

See a number that looks wrong?